Tag: erenumab

American Academy of Pediatrics recommends standards for adverse event disclosures

Erenumab linked to decreased episodic migraine frequency: The STRIVE trial

byShani Chibberand1 others

December 1, 2017

1. Monthly injections of erenumab were associated with reduced migraine frequency, decreased use of acute migraine medication, and decreased migraine ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient-Reported Outcomes in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Withdrawal Trial
Weekly islatravir plus lenacapavir maintains HIV virologic suppression
Certain cannabis-based products may offer modest reductions in pain

No Result

View All Result